Avanos Medical (AVNS) Liabilities and Shareholders Equity (2016 - 2024)
Historic Liabilities and Shareholders Equity for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $1.7 billion.
- Avanos Medical's Liabilities and Shareholders Equity fell 398.28% to $1.7 billion in Q3 2024 from the same period last year, while for Dec 2024 it was $5.0 billion, marking a year-over-year decrease of 2703.66%. This contributed to the annual value of $1.7 billion for FY2023, which is 528.85% down from last year.
- As of Q3 2024, Avanos Medical's Liabilities and Shareholders Equity stood at $1.7 billion, which was down 398.28% from $1.7 billion recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q3 2020 and a low of $1.6 billion during Q3 2021
- Over the past 5 years, Avanos Medical's median Liabilities and Shareholders Equity value was $1.7 billion (recorded in 2023), while the average stood at $1.7 billion.
- In the last 5 years, Avanos Medical's Liabilities and Shareholders Equity plummeted by 1118.34% in 2021 and then skyrocketed by 1143.05% in 2022.
- Avanos Medical's Liabilities and Shareholders Equity (Quarter) stood at $1.7 billion in 2020, then dropped by 4.14% to $1.6 billion in 2021, then rose by 11.43% to $1.8 billion in 2022, then decreased by 5.29% to $1.7 billion in 2023, then decreased by 2.14% to $1.7 billion in 2024.
- Its last three reported values are $1.7 billion in Q3 2024, $1.7 billion for Q2 2024, and $1.7 billion during Q1 2024.